Pfizer and OPKO's Once-Weekly NGENLA Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency Life Science Investing
European Medicines Agency Approves Pfizer's 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults Life Science Investing
Bristol Myers Squibb Announces Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion Pharmaceutical Investing
BetterLife Lead Drug Promotes Structural Neural Plasticity in Preclinical Model Pharmaceutical Investing
AbbVie and the University of Toronto Establish Endowed Chair in Ethnodermatology Pharmaceutical Investing
Opdivo® in Combination with CABOMETYX® Demonstrates Continued Survival Benefits with Over Two Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma Pharmaceutical Investing
LYNPARZA® Plus Abiraterone Reduced Risk of Disease Progression or Death by 34% Versus Abiraterone in First-Line Metastatic Castration-Resistant Prostate Cancer, Regardless of Biomarker Status Life Science Investing
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea Life Science Investing
Merck to Hold Event to Discuss Long-Term Environmental, Social & Governance Priorities Life Science Investing
Phase 2/3 Interim Data Evaluating the Safety, Tolerability and Clinical Outcomes of Veklury® in Pediatric Patients With COVID-19 Presented at CROI 2022 Pharmaceutical Investing
